CONMED’s shares receive ‘hold’ rating — 5 points

Zacks upgraded CONMED’s shares to a ‘hold’ rating on Nov. 19, according to Dakota Financial News.

Advertisement

Here are five points:

 

1. Zacks stated CONMED’s sales were negatively impacted by foreign exchange.

 

2. CONMED’s shares traded up 0.84 percent to $42.17 on Nov. 19.

 

3. On Nov. 19, 15,771 shares were exchanged.

 

4. The company has a 12-month-low of $37.94 and a 12-month-high of $60.66.

 

5. Its 50-day moving average is $44.04 and its 200-day moving average is $52.43.

 

More articles on devices:
Memorial Medical Center gets new surgical system — 5 key points
New Bay Area device uses a precise knee replacement for surfer — 4 things to know
Dr. Richard Buch performs surgery using rare Implantcast — 7 key facts

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.